# Pharmacodynamic and Safety of MEDITOXIN® in Healthy Male Volunteers

> **NCT03317717** · PHASE1 · COMPLETED · sponsor: **Medy-Tox** · enrollment: 25 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Meditoxin
- **DRUG:** Botox

## Key facts

- **NCT ID:** NCT03317717
- **Lead sponsor:** Medy-Tox
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-12
- **Primary completion:** 2018-01-30
- **Final completion:** 2018-01-30
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2019-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03317717

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03317717, "Pharmacodynamic and Safety of MEDITOXIN® in Healthy Male Volunteers". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03317717. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*